🏛️ Verified NIH Record • Updated 2026-07-27

Medication Treatment of ADHD in Pediatric Epilepsy (NCT07594652)

Use of JornayPM® to Treat ADHD in Pediatric Epilepsy

🟢 Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

🩺 Plain-English Summary (8th-Grade Level)

This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.

Who can join: Review the eligibility criteria below.

Location: Kennedy Krieger Institute — Baltimore, Maryland

Age range: 6 Years to 17 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • Kennedy Krieger Institute — Baltimore, Maryland

📞 Contact the Study Coordinator

Phone: (443) 923-7612

Email: ertenu@kennedykrieger.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in ADHD - Attention Deficit Disorder With Hyperactivity

Explore by condition: All ADHD - Attention Deficit Disorder With Hyperactivity clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗